[1]林少梅　沈云珠　施晓宁　林适峰　陈明珠.PDCA循环管理在注射用重组人脑利钠肽专项点评中的应用[J].大众科技,2022,24(09):155-158.
　Application of PDCA Cycle Management in Special Review of Recombinant Human Brain Natriuretic Peptide for Injection[J].Popular Science & Technology,2022,24(09):155-158.
点击复制

PDCA循环管理在注射用重组人脑利钠肽 专项点评中的应用()
分享到：

《大众科技》[ISSN:1008-1151/CN:45-1235/N]

卷:
24
期数:
2022年09
页码:
155-158
栏目:
医药与卫生
出版日期:
2022-09-20

文章信息/Info

Title:
Application of PDCA Cycle Management in Special Review of Recombinant Human Brain Natriuretic Peptide for Injection
作者:
林少梅1　沈云珠2　施晓宁2　林适峰3　陈明珠1　
（1.泉州医学高等专科学校，福建 泉州 362100； 　2.福建医科大学附属第二医院，福建 泉州 362100； 3.泉州市中医联合医院，福建 泉州 362100）
关键词:
注射用重组人脑利钠肽; PDCA循环; 专项点评; 合理用药
Keywords:
recombinant human brain natriuretic peptide for injection PDCA cycle special review rational drug use
文献标志码:
A
摘要:
目的：探讨PDCA循环管理在注射用重组人脑利钠肽专项点评中的应用，促进临床合理使用注射用重组人脑利钠肽。方法：运用PDCA循环管理法分析医院临床使用注射用重组人脑利钠肽存在的问题，寻找原因，制定对策并实施干预措施，比较管理前后注射用重组人脑利钠肽的使用量、使用金额及使用的合理率。结果：经过管控和干预后，注射用重组人脑利钠肽的销售金额从2018年第三季度的563 940元下降至2019年第一季度的506 025元。季度使用量有所减少，使用日趋规范，合理率显著提高，并持续两个月抽样点评合理率维持在100%。结论：PDCA循环管理法用于注射用重组人脑利钠肽的专项点评效果较好，使注射用重组人脑利钠肽的使用更加规范、合理。
Abstract:
Objective: To explore the application of PDCA circulation management in the special review of recombinant human brain natriuretic peptide for injection and promote the rational use of recombinant human brain natriuretic peptide for injection in clinic. Methods: To explore the application of PDCA circulation management in the special review of recombinant human brain natriuretic peptide for injection and promote the rational use of recombinant human brain natriuretic peptide for injection in clinic. Methods PDCA circulation management method was used to analyze the problems existing in the clinical use of recombinant human brain natriuretic peptide for injection in the hospital, find out the reasons, formulate countermeasures and implement intervention measures, and compare the usage, amount and reasonable rate of use of recombinant human brain natriuretic peptide for injection before and after the management. Results: After control and intervention, the sales amount of recombinant human brain natriuretic peptide for injection decreased from 563 940 yuan in the third quarter of 2018 to 506 025 in the first quarter of 2019. The quarterly usage has been decreased, the usage has become more standardized, and the reasonable rate has been significantly improved, and the reasonable rate of sampling comments has been maintained at 100% for two months. Conclusion: PDCA cycle management method has a good effect on the special comments on recombinant human brain natriuretic peptide for injection, which makes the use of recombinant human brain natriuretic peptide for injection more standardized and reasonable.

参考文献/References:

[1] 殷召军. 临床药师在控制医保药品费用中的作用及建议[J]. 中国处方，2018，16(12): 13-15. [2] 姚舜杰，王翠艳. 新活素治疗心力衰竭的研究进展[J]. 心血管病防治知识，2016(9): 152-154.  [3] 许红蕾，杜欣，孙婧. 抗心衰药物治疗研究进展[J]. 天津药学，2014，26(5): 63-67. [4] Farnsworth C W, Bailey A L, Jaffe A S, et al. Diagnostic concordance between NT-proBNP and BNP for suspected heart failure[J]. Clinical Biochemistry, 2018(59): 50-55. [5] Colucci W S, Elkayam U, Horton D P, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure[J]. New England Journal of Medicine, 2000, 343(4): 246-253. [6] 张彬，曲凤霞，崔美平，等. 冻干重组人脑利钠肽对急性心肌梗死合并心力衰竭患者NT-proBNP及心功能的影响[J]. 实用临床医药杂志，2015，19(23): 1-3，11. [7] Elkayam U, Akhter M W, Singh H, et al. Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure[J]. American Journal of Cardiology, 2004, 93(2): 237-240. [8] 廖华，郭小梅. 慢性心力衰竭诊断与治疗新进展[J]. 心血管学进展，2011，32(1): 94- 97. [9] 游巍，钱峰. 重组人脑利钠肽联合多巴胺对老年慢性心力衰竭患者心功能及血清炎症因子的影响[J]. 中国药物应用与监测，2017，14(4): 197-200. [10] 李应华. 冻干重组人脑利钠肽联合比索洛尔及左西孟旦治疗缺血性心肌病急性心力衰竭的疗效观察[J]. 现代诊断与治疗，2019，30(4): 590-591. [11] 孟鑫. 冻干重组人脑利钠肽联合米力农治疗急性心力衰竭的临床疗效研究[J]. 中国医药指南，2019，17(16): 86. [12] Zhang J, Fu X, Jia X, et al. B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention[J]. Acta Radiologica, 2010, 51(6): 641-648. [13] Peacock W F, Holland R, Gyarmathy R, et al. Observation unit treatment of heart failure with nesiritide: results from the proaction trial[J]. Journal of Emergency Medicine, 2005, 29(3): 243-252. [14] 韩姗姗，赵翠萍. 重组人脑利钠肽在心力衰竭治疗中的研究进展[J]. 临床药物治疗杂志，2019，17(2): 28-31.

相似文献/References:

[1]张玉兰.PDCA循环在护理管理中的应用进展[J].大众科技,2022,24(09):130.
　Application Progress of PDCA Cycle in Nursing Management[J].Popular Science & Technology,2022,24(09):130.
[2]彭玲玲.CBL教学联合PDCA循环在西医高等院校中医辨证见习教学中的应用[J].大众科技,2023,25(8):173.
　Application of CBL Teaching Combined with PDCA Circulation in Traditional Chinese Medicine Syndrome Differentiation Internship Teaching in Western Medical Colleges and Universities[J].Popular Science & Technology,2023,25(09):173.

备注/Memo

备注/Memo:
【收稿日期】2022-04-30 【作者简介】林少梅（1990－），女，泉州医学高等专科学校助教，研究方向为药理学。 【通信作者】沈云珠（1987－），福建医科大学附属第二医院主管药师，硕士，研究方向为药学。
更新日期/Last Update: 2022-10-14